Phase II Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) in Surgically Operable Stage I Non-Small Cell Lung Cancer (STARS)

被引：0

作者：

Chang, Joe Y. ^{[1
]}

Mehran, Reza ^{[2
]}

Balter, Peter ^{[1
]}

Mcrae, Stephen ^{[3
]}

Feng, Lei ^{[4
]}

Berry, Donald ^{[4
]}

Komaki, Ritsuko U. ^{[1
]}

Roth, Jack ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Radiat Oncol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Thorac Surg, Houston, AL USA

[3] Univ Texas MD Anderson Canc Ctr, Radiol, Houston, AL USA

[4] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, AL USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

operable Stage I lung cancer; stereotactic radiotherapy; SBRT; SABR;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.02-032

引用

页码：S563 / S563

页数：1

共 50 条

[11] Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
Siva, Shankar
Ball, David
ONCOLOGIST, 2016, 21 (04): : 393 - 398
[12] Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
Chang, J. Y.
Lin, S. H.
Dong, W.
Liao, Z.
Gandhi, S.
Chun, S. G.
Gay, C. M.
Zhang, J.
Fossella, F. V.
Blumenschein, G. R.
Cascone, T.
Le, X.
Pozadzides, J. V.
Tsao, A.
Mehmet, A.
Welsh, J. W.
Verma, V.
Wistuba, I. I.
Lee, J.
Heymach, J.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S71 - S71
[13] Phase II randomized clinical trial comparing immunotherapy plus stereotactic ablative radiotherapy (I-SABR) versus SABR alone for stage I, selected stage IIa or isolated lung parenchymal recurrent non-small cell lung cancer: I-SABR.
Chang, Joe Y.
Feng, Lei
Lin, Steven H.
Welsh, James William
Antonoff, Mara
Gomez, Daniel Richard
Heymach, John
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[14] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
Pascoe, A. C.
Foweraker, K.
Esler, C.
Morgan, S.
Wallace, A.
Launders, D.
Harron, E.
CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
[15] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
Beal, J.
Gomes, D.
Taranto, P.
Koch, L.
Rezende, A. C.
Samano, M.
Bibas, B.
Gomes, O.
Campregher, P.
Severino, P.
Marti, L.
Paes, V.
Chate, R.
Sales, D.
Schvartsman, G.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652
[16] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
Leschenko, Y.
Chebotareva, T.
Spizhenko, N.
Fedusenko, A.
Sharaevskiy, O.
Buryk, V.
RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
[17] Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
Mirimanoff, Rene-Olivier
CHINESE CLINICAL ONCOLOGY, 2015, 4 (04)
[18] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER: A COMPARISON OF PATIENTS WITH AND WITHOUT PATHOLOGICAL PROOF
Verstegen, Naomi E.
Lagerwaard, Frank J.
Haasbeek, Cornelis J.
Slotman, Ben
Senan, Suresh
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S281 - S282
[19] Curative Treatment Rates and Use of Stereotactic Ablative Radiotherapy (SABR) for Stage I Non-small Cell Lung Cancer (NSCLC) in England
Harden, S.
CLINICAL ONCOLOGY, 2018, 30 (06) : E50 - E50
[20] STEREOTACTIC ABLATIVE RADIOTHERAPY OF EARLY STAGE NON-SMALL CELL LUNG CANCER
Cvek, Jakub
Feltl, David
Knybel, Lukas
Otahal, Bretislav
Skacelikova, Eva
Binarova, Andrea
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S537 - S537

← 1 2 3 4 5 →